ImmunoGen
IMGN
#1871
Rank
โ‚ฌ7.68 B
Marketcap
27,51ย โ‚ฌ
Share price
0.00%
Change (1 day)
120.63%
Change (1 year)

Revenue for ImmunoGen (IMGN)

Revenue in 2023 (TTM): โ‚ฌ0.26 Billion

According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.25 Billion. In 2022 the company made a revenue of โ‚ฌ0.10 Billion an increase over the revenue in the year 2021 that were of โ‚ฌ61.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoGen from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ0.26 B164.03%
2022 โ‚ฌ0.10 B64.41%
2021 โ‚ฌ61.68 M-42.65%
2020 โ‚ฌ0.10 B46.46%
2019 โ‚ฌ73.44 M57.2%
2018 โ‚ฌ46.71 M-51.44%
2017 โ‚ฌ96.21 M
2015 โ‚ฌ52.05 M-14.58%
2014 โ‚ฌ60.94 M10.58%
2013 โ‚ฌ55.11 M464.81%
2012 โ‚ฌ9.75 M-42.06%
2011 โ‚ฌ16.83 M46.16%
2010 โ‚ฌ11.52 M-11.89%
2009 โ‚ฌ13.07 M-47.06%
2008 โ‚ฌ24.7 M-8.8%
2007 โ‚ฌ27.08 M-4.86%
2006 โ‚ฌ28.46 M5.29%
2005 โ‚ฌ27.03 M4.93%
2004 โ‚ฌ25.76 M173.56%
2003 โ‚ฌ9.41 M27.3%
2002 โ‚ฌ7.39 M22.4%
2001 โ‚ฌ6.04 M-25.09%
2000 โ‚ฌ8.07 M-17.97%
1999 โ‚ฌ9.83 M1067.48%
1998 โ‚ฌ0.84 M150%
1997 โ‚ฌ0.33 M0%
1996 โ‚ฌ0.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ2.02 B 699.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.43 B 11,521.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.67 B 15,560.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.54 B 16,693.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.23 B 30,782.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.04 B 22,022.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.55 B 17,883.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ42.24 B 16,575.25%๐Ÿ‡ซ๐Ÿ‡ท France